Updated Results From A Phase I/Ii Study Of Duvelisib And Venetoclax In Patients With Relapsed Or Refractory Cll/Sll Or Richter'S Syndrome

BLOOD(2020)

引用 14|浏览22
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要